Genomics Market by Product, Services, Technology, Study Type, Application

Description

List of Tables

The global genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, exhibiting a CAGR of 12.6% from 2025 to 2030. The genomics market is experiencing strong growth, driven by increasing government funding, the rising prevalence of viral and hereditary diseases, and ongoing advancements in next-generation sequencing (NGS) technologies.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Offering, Products, Services, Technology, Applications and Study type
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Beyond traditional applications in genetic disorder identification and drug discovery, genomics is gaining traction in agriculture, veterinary science, and forensics. In forensics, the adoption of NGS has revolutionized DNA analysis. Traditional DNA fingerprinting methods are being replaced by comprehensive genomic reconstruction, enabling more precise identification. NGS also facilitates on-site analysis, allowing the extraction of detailed genetic information from trace or degraded DNA samples, thereby enhancing the accuracy and scope of forensic investigations.

"The reagents, kits, and consumables segment is projected to record the highest CAGR during the forecast period."

Based on product type, the genomics market is segmented into reagents, kits, and consumables; instruments; and bioinformatics tools. The reagents, kits, and consumables segment accounted for the largest share of the product market. Reagents and kits are essential for nearly all genomic workflows, including DNA and RNA extraction, amplification, sequencing, and analysis. They are vital for both research and clinical applications. The demand for these products is driven by the increasing number of genomic experiments conducted in diagnostics, personalized medicine, and drug development. Each workflow requires a consistent supply of high-quality reagents and kits to ensure the accurate and reliable generation of genomic data.

Moreover, the rapid adoption of advanced technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) further increases the need for application-specific reagents and consumables. The ongoing growth in genomics sectors, such as healthcare, research, and biotechnology, enhances the revenue generated from consumables, solidifying its leading market position.

"The hospitals, diagnostic laboratories, and clinics segment accounted for the largest share in 2024."

In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the global genomic products market. The large share of this end-user segment can be attributed to increased patient engagement in genomic research, driven by citizen science initiatives. These efforts aim to democratize data collection and accelerate discoveries in rare diseases and personalized medicine. Additionally, pharmaceutical & biotechnology companies hold the second-largest share in this segment.

"The US dominated the North American genomics market in 2024."

The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for genomics products & services is expected to grow over the coming years, driven by its advanced research ecosystem, strong funding support, and presence of major industry leaders such as Illumina, Thermo Fisher Scientific, Agilent Technologies, and Danaher. The country benefits from substantial government and private investments in precision medicine and population genomics programs, including NIH and All of Us initiatives. High adoption of next-generation sequencing (NGS) and bioinformatics platforms across clinical and research settings further supports market leadership. Additionally, a well-established regulatory framework, robust healthcare infrastructure, and active public-private collaborations foster continuous innovation and commercialization of genomic technologies in the US.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side (70%) and Demand Side (30%)
By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US) are some of the key players operating in the genomics market.

Research Coverage:

This research report categorizes the genomics market by offering {products [type (reagents, kits, and consumables; instruments; and bioinformatics tools), technology (sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies), and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; CROs; and other end users)] and services [type (genomics profiling and sequencing services, sample preparation and library preparation services, and bioinformatics services) and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; and other end users)]}, application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), study type (functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The report's scope encompasses detailed information regarding the key factors, including drivers, restraints, challenges, and opportunities, that influence market growth. A thorough analysis of key industry players has provided insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are recent developments in the genomics market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

Analysis of key drivers (increasing government funding for genomics projects, increasing prevalence of viral and inherited disorders, advancements in NGS platforms, and growing applications of genomics), restraints (high investment costs), opportunities (increasing use of genomics in precision medicine and technological advancements in genomics), and challenges (handling of large volume of data sets and their analysis and clinical utility of genomics) influencing the growth of the market.
Product Development/Innovation: Detailed insights on newly launched products/services of the genomics market.
Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the genomics market.
Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US), among others in the market.

Product Code: BT 2209

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.3.5 UNITS CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key objectives of secondary research
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Breakdown of primaries
  - 2.1.2.2 Key objectives of primary research
2.2 MARKET SIZE ESTIMATION
- 2.2.1 GLOBAL GENOMICS MARKET ESTIMATION, 2024
  - 2.2.1.1 Company revenue analysis (bottom-up approach)
  - 2.2.1.2 MNM repository analysis
  - 2.2.1.3 Primary research
- 2.2.2 SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
3.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS
3.3 DISRUPTIVE TRENDS SHAPING GENOMICS MARKET
3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS

4 PREMIUM INSIGHTS

4.1 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
4.2 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION AND COUNTRY, 2024
4.3 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing government funding for genomics projects
  - 5.2.1.2 Increasing prevalence of viral and inherited disorders
  - 5.2.1.3 Advancements in NGS platforms
  - 5.2.1.4 Growing applications of genomics
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High investment costs
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Increasing use of genomics in precision medicine
  - 5.2.3.2 Technological advancements in genomics
- 5.2.4 CHALLENGES
  - 5.2.4.1 Handling large volumes of data sets and their analysis
  - 5.2.4.2 Clinical utility of genomics
5.3 UNMET NEEDS AND WHITE SPACES
5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
5.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

6 INDUSTRY TRENDS

6.1 PORTER'S FIVE FORCES ANALYSIS
- 6.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 6.1.2 BARGAINING POWER OF SUPPLIERS
- 6.1.3 BARGAINING POWER OF BUYERS
- 6.1.4 THREAT OF SUBSTITUTES
- 6.1.5 THREAT OF NEW ENTRANTS
6.2 MACROECONOMIC OUTLOOK
- 6.2.1 INTRODUCTION
- 6.2.2 GDP TRENDS AND FORECAST
- 6.2.3 TRENDS IN GLOBAL GENOMICS INDUSTRY
6.3 VALUE CHAIN ANALYSIS
6.4 ECOSYSTEM ANALYSIS
- 6.4.1 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
6.5 PRICING ANALYSIS
- 6.5.1 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024
- 6.5.2 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024
- 6.5.3 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024
- 6.5.4 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024
6.6 TRADE ANALYSIS
- 6.6.1 IMPORT SCENARIO (HS CODE 3822 & 902789)
- 6.6.2 EXPORT SCENARIO (HS CODE 3822 & 902789)
6.7 KEY CONFERENCES AND EVENTS, 2026
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
6.9 INVESTMENT AND FUNDING SCENARIO
- 6.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
6.10 CASE STUDY ANALYSIS
6.11 IMPACT OF 2025 US TARIFFS-GENOMICS MARKET
- 6.11.1 INTRODUCTION
- 6.11.2 KEY TARIFF RATES
- 6.11.3 PRICE IMPACT ANALYSIS
- 6.11.4 IMPACT ON COUNTRIES/REGIONS
  - 6.11.4.1 US
  - 6.11.4.2 Europe
  - 6.11.4.3 Asia Pacific
- 6.11.5 IMPACT ON END-USE INDUSTRIES
  - 6.11.5.1 Pharmaceutical & biotechnology companies
  - 6.11.5.2 CROs and academic & research institutes
  - 6.11.5.3 Hospitals, diagnostic laboratories, and clinics

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

7.1 TECHNOLOGICAL ANALYSIS
- 7.1.1 KEY EMERGING TECHNOLOGIES
  - 7.1.1.1 Sequencing by synthesis
  - 7.1.1.2 Single-molecule real-time sequencing
  - 7.1.1.3 Nanopore sequencing
  - 7.1.1.4 qPCR
  - 7.1.1.5 dPCR
  - 7.1.1.6 Microarray technology
- 7.1.2 COMPLEMENTARY TECHNOLOGIES
  - 7.1.2.1 Cytogenetics
  - 7.1.2.2 Synthetic biology
  - 7.1.2.3 Multiomics
  - 7.1.2.4 Single-cell analysis
- 7.1.3 ADJACENT TECHNOLOGIES
  - 7.1.3.1 Bioinformatics and computational biology
  - 7.1.3.2 Artificial intelligence and machine learning
7.2 TECHNOLOGY/PRODUCT ROADMAP
7.3 PATENT ANALYSIS
- 7.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014-2024
7.4 FUTURE APPLICATIONS
7.5 IMPACT OF AI/GEN AI ON GENOMICS MARKET
- 7.5.1 BEST PRACTICES IN GENOMICS WORKFLOW
- 7.5.2 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET
- 7.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 7.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN GENOMICS MARKET

8 SUSTAINABILITY AND REGULATORY LANDSCAPE

8.1 REGIONAL REGULATIONS AND COMPLIANCE
- 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 8.1.2 INDUSTRY STANDARDS
8.2 SUSTAINABILITY INITIATIVES
8.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
8.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

9.1 DECISION-MAKING PROCESS
9.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 9.2.2 KEY BUYING CRITERIA, BY END USER
9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9.5 MARKET PROFITABILITY

10 GENOMICS MARKET, BY OFFERING

10.1 INTRODUCTION
10.2 PRODUCTS
- 10.2.1 ACCELERATION OF HIGH-THROUGHPUT GENOMICS DRIVEN BY PLATFORM INNOVATION AND AUTOMATION IS BOOSTING GROWTH
10.3 SERVICES
- 10.3.1 RAPID EXPANSION OF GENOMIC SERVICES FUELED BY CLINICAL ADOPTION AND DATA-DRIVEN DECISION SUPPORT

11 GENOMICS PRODUCTS MARKET, BY TYPE

11.1 INTRODUCTION
11.2 REAGENTS, KITS, AND CONSUMABLES
- 11.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR REAGENTS, KITS, AND CONSUMABLES
11.3 INSTRUMENTS
- 11.3.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
11.4 BIOINFORMATICS TOOLS
- 11.4.1 ACCELERATING GENOMIC INSIGHTS THROUGH SCALABLE, AI-ENABLED BIOINFORMATICS PLATFORMS DRIVE MARKET GROWTH

12 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY

12.1 INTRODUCTION
12.2 SEQUENCING
- 12.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
12.3 PCR
- 12.3.1 RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH
12.4 GENE EDITING
- 12.4.1 RISING DEMAND FOR NEWER THERAPEUTIC APPROACHES DRIVING GROWTH
12.5 FLOW CYTOMETRY
- 12.5.1 RISING DEMAND FOR FLOW CYTOMETRY IN AGRIGENOMICS TO DRIVE MARKET GROWTH
12.6 MICROARRAYS
- 12.6.1 RISING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES LIMITING MARKET GROWTH
12.7 IN SITU HYBRIDIZATION
- 12.7.1 INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS DRIVING GROWTH
12.8 OTHER TECHNOLOGIES

13 GENOMICS PRODUCTS MARKET, BY END USER

13.1 INTRODUCTION
13.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
- 13.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
13.3 ACADEMIC & RESEARCH INSTITUTES
- 13.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
13.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS PROPELS MARKET
13.5 CROS
- 13.5.1 RISING COLLABORATION BETWEEN PHARMA COMPANIES AND CROS DRIVING MARKET GROWTH
13.6 OTHER END USERS

14 GENOMICS SERVICES MARKET, BY TYPE

14.1 INTRODUCTION
14.2 GENOMIC PROFILING & SEQUENCING SERVICES
- 14.2.1 INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH
14.3 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES
- 14.3.1 INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH
14.4 BIOINFORMATICS SERVICES
- 14.4.1 RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH

15 GENOMICS SERVICES MARKET, BY END USER

15.1 INTRODUCTION
15.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
- 15.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
15.3 ACADEMIC & RESEARCH INSTITUTES
- 15.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
15.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 15.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH
15.5 OTHER END USERS

16 GENOMICS MARKET, BY APPLICATION

16.1 INTRODUCTION
16.2 DRUG DISCOVERY & DEVELOPMENT
- 16.2.1 DRUG DISCOVERY & DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET
16.3 DIAGNOSTICS
- 16.3.1 CANCER DIAGNOSTICS
  - 16.3.1.1 Rising demand for targeted therapies to drive market growth
- 16.3.2 INFECTIOUS DISEASES
  - 16.3.2.1 Rising demand for comprehensive genomic data in clinical genomics to drive market growth
- 16.3.3 REPRODUCTIVE HEALTH
  - 16.3.3.1 Rising focus on genetic diseases to drive market growth
- 16.3.4 OTHER DIAGNOSTIC APPLICATIONS
16.4 AGRICULTURE & ANIMAL RESEARCH
- 16.4.1 GENOMICS TO HELP IMPROVE CROP PRODUCTIVITY
16.5 OTHER APPLICATIONS

17 GENOMICS MARKET, BY STUDY TYPE

17.1 INTRODUCTION
17.2 FUNCTIONAL GENOMICS
- 17.2.1 INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES TO DRIVE MARKET GROWTH
17.3 BIOMARKER DISCOVERY
- 17.3.1 RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
17.4 PATHWAY ANALYSIS
- 17.4.1 RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH
17.5 EPIGENOMICS
- 17.5.1 RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH
17.6 OTHER STUDY TYPES

18 GENOMICS MARKET, BY REGION

18.1 INTRODUCTION
18.2 NORTH AMERICA
- 18.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 18.2.2 US
  - 18.2.2.1 US expected to dominate market in North America
- 18.2.3 CANADA
  - 18.2.3.1 Increasing government initiatives in genomics research to boost market growth
18.3 EUROPE
- 18.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 18.3.2 GERMANY
  - 18.3.2.1 Germany to dominate European genomics market
- 18.3.3 UK
  - 18.3.3.1 Strategic initiatives and funding for genomics research to support market growth
- 18.3.4 FRANCE
  - 18.3.4.1 Increasing government investment in genomics research to drive growth
- 18.3.5 ITALY
  - 18.3.5.1 Favorable funding scenario to drive adoption of advanced sequencing technology
- 18.3.6 SPAIN
  - 18.3.6.1 Growing focus on advancements in personalized medicine to support market growth
- 18.3.7 REST OF EUROPE
18.4 ASIA PACIFIC
- 18.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 18.4.2 CHINA
  - 18.4.2.1 China to dominate Asia Pacific market during forecast period
- 18.4.3 JAPAN
  - 18.4.3.1 Rising number of collaborations in genomics to drive market
- 18.4.4 INDIA
  - 18.4.4.1 Government and private initiatives for genomics to propel market
- 18.4.5 AUSTRALIA
  - 18.4.5.1 Increased genomics research in Australia to support market growth
- 18.4.6 SOUTH KOREA
  - 18.4.6.1 Demand for advanced sequencing technologies to support market growth in South Korea
- 18.4.7 REST OF ASIA PACIFIC
18.5 LATIN AMERICA
- 18.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 18.5.2 BRAZIL
  - 18.5.2.1 Increased government investments in genomics advancements to drive market in Brazil
- 18.5.3 MEXICO
  - 18.5.3.1 Rising demand for chronic disease treatment to support market growth in Mexico
- 18.5.4 REST OF LATIN AMERICA
18.6 MIDDLE EAST
- 18.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
- 18.6.2 GCC COUNTRIES
  - 18.6.2.1 Saudi Arabia
    - 18.6.2.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth
  - 18.6.2.2 United Arab Emirates
    - 18.6.2.2.1 Growing collaborations to advance genome sequencing to aid market growth in UAE
  - 18.6.2.3 Rest of GCC Countries
- 18.6.3 REST OF MIDDLE EAST
18.7 AFRICA
- 18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA
- 18.7.2 AFRICA: MACROECONOMIC OUTLOOK

19 COMPETITIVE LANDSCAPE

19.1 INTRODUCTION
19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENOMICS MARKET
19.3 REVENUE ANALYSIS, 2020-2024
19.4 MARKET SHARE ANALYSIS, 2024
19.5 BRAND/PRODUCT COMPARISON
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 19.6.1 STARS
- 19.6.2 EMERGING LEADERS
- 19.6.3 PERVASIVE PLAYERS
- 19.6.4 PARTICIPANTS
- 19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 19.6.5.1 Company footprint
  - 19.6.5.2 Region footprint
  - 19.6.5.3 Product footprint
  - 19.6.5.4 Application footprint
  - 19.6.5.5 Technology footprint
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 19.7.1 PROGRESSIVE COMPANIES
- 19.7.2 RESPONSIVE COMPANIES
- 19.7.3 DYNAMIC COMPANIES
- 19.7.4 STARTING BLOCKS
- 19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 19.7.5.1 Detailed list of key startups/SMEs
  - 19.7.5.2 Competitive benchmarking of key startups/SMEs
19.8 COMPANY VALUATION & FINANCIAL METRICS
- 19.8.1 FINANCIAL METRICS
- 19.8.2 COMPANY VALUATION
19.9 COMPETITIVE SCENARIO
- 19.9.1 PRODUCT LAUNCHES
- 19.9.2 DEALS
- 19.9.3 EXPANSIONS

20 COMPANY PROFILES

20.1 INTRODUCTION
20.2 KEY PLAYERS
- 20.2.1 THERMO FISHER SCIENTIFIC INC.
  - 20.2.1.1 Business overview
  - 20.2.1.2 Products/Services offered
  - 20.2.1.3 Recent developments
    - 20.2.1.3.1 Product launches and approvals
    - 20.2.1.3.2 Deals
    - 20.2.1.3.3 Expansions
  - 20.2.1.4 MnM view
    - 20.2.1.4.1 Key strengths
    - 20.2.1.4.2 Strategic choices
    - 20.2.1.4.3 Weaknesses and competitive threats
- 20.2.2 ILLUMINA, INC.
  - 20.2.2.1 Business overview
  - 20.2.2.2 Products/Services offered
  - 20.2.2.3 Recent developments
    - 20.2.2.3.1 Product launches and approvals
    - 20.2.2.3.2 Deals
    - 20.2.2.3.3 Expansions
    - 20.2.2.3.4 Other developments
  - 20.2.2.4 MnM view
    - 20.2.2.4.1 Key strengths
    - 20.2.2.4.2 Strategic choices
    - 20.2.2.4.3 Weaknesses and competitive threats
- 20.2.3 DANAHER CORPORATION
  - 20.2.3.1 Business overview
  - 20.2.3.2 Products/Services offered
  - 20.2.3.3 Recent developments
    - 20.2.3.3.1 Product launches
    - 20.2.3.3.2 Deals
    - 20.2.3.3.3 Expansions
  - 20.2.3.4 MnM view
    - 20.2.3.4.1 Key strengths
    - 20.2.3.4.2 Strategic choices
    - 20.2.3.4.3 Weaknesses and competitive threats
- 20.2.4 F. HOFFMANN-LA ROCHE LTD.
  - 20.2.4.1 Business overview
  - 20.2.4.2 Products/Services offered
    - 20.2.4.2.1 Product launches
    - 20.2.4.2.2 Deals
    - 20.2.4.2.3 Other developments
  - 20.2.4.3 MnM view
    - 20.2.4.3.1 Key strengths
    - 20.2.4.3.2 Strategic choices
    - 20.2.4.3.3 Weaknesses and competitive threats
- 20.2.5 AGILENT TECHNOLOGIES, INC.
  - 20.2.5.1 Business overview
  - 20.2.5.2 Products/Services offered
  - 20.2.5.3 Recent developments
    - 20.2.5.3.1 Product launches
    - 20.2.5.3.2 Deals
    - 20.2.5.3.3 Expansions
  - 20.2.5.4 MnM view
    - 20.2.5.4.1 Key strengths
    - 20.2.5.4.2 Strategic choices
    - 20.2.5.4.3 Weaknesses and competitive threats
- 20.2.6 QIAGEN
  - 20.2.6.1 Business overview
  - 20.2.6.2 Products/Services offered
  - 20.2.6.3 Recent developments
    - 20.2.6.3.1 Product launches and approvals
    - 20.2.6.3.2 Deals
    - 20.2.6.3.3 Expansions
- 20.2.7 REVVITY
  - 20.2.7.1 Business overview
  - 20.2.7.2 Products/Services offered
  - 20.2.7.3 Recent developments
    - 20.2.7.3.1 Product launches
    - 20.2.7.3.2 Deals
    - 20.2.7.3.3 Expansions
- 20.2.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
  - 20.2.8.1 Business overview
  - 20.2.8.2 Services offered
  - 20.2.8.3 Recent developments
    - 20.2.8.3.1 Service launches
    - 20.2.8.3.2 Deals
    - 20.2.8.3.3 Expansions
- 20.2.9 IQVIA INC.
  - 20.2.9.1 Business overview
  - 20.2.9.2 Services offered
  - 20.2.9.3 Recent developments
    - 20.2.9.3.1 Deals
- 20.2.10 CHARLES RIVER LABORATORIES
  - 20.2.10.1 Business overview
  - 20.2.10.2 Services offered
- 20.2.11 BIO-RAD LABORATORIES, INC.
  - 20.2.11.1 Business overview
  - 20.2.11.2 Products/Services offered
  - 20.2.11.3 Recent developments
    - 20.2.11.3.1 Product launches and approvals
    - 20.2.11.3.2 Deals
- 20.2.12 EUROFINS SCIENTIFIC
  - 20.2.12.1 Business overview
  - 20.2.12.2 Products/Services offered
  - 20.2.12.3 Recent developments
    - 20.2.12.3.1 Product launches
    - 20.2.12.3.2 Deals
- 20.2.13 PACBIO
  - 20.2.13.1 Business overview
  - 20.2.13.2 Products/Services offered
  - 20.2.13.3 Recent developments
    - 20.2.13.3.1 Product launches
    - 20.2.13.3.2 Deals
    - 20.2.13.3.3 Expansions
    - 20.2.13.3.4 Other developments
- 20.2.14 OXFORD NANOPORE TECHNOLOGIES PLC.
  - 20.2.14.1 Business overview
  - 20.2.14.2 Products/Services offered
  - 20.2.14.3 Recent developments
    - 20.2.14.3.1 Product launches
    - 20.2.14.3.2 Deals
    - 20.2.14.3.3 Expansions
- 20.2.15 TAKARA BIO INC.
  - 20.2.15.1 Business overview
  - 20.2.15.2 Products/Services offered
  - 20.2.15.3 Recent developments
    - 20.2.15.3.1 Product launches
    - 20.2.15.3.2 Deals
- 20.2.16 BGI GROUP
  - 20.2.16.1 Business overview
  - 20.2.16.2 Products/Services offered
  - 20.2.16.3 Recent developments
    - 20.2.16.3.1 Product & service launches and approvals
    - 20.2.16.3.2 Deals
    - 20.2.16.3.3 Other developments
- 20.2.17 EPPENDORF SE
  - 20.2.17.1 Business overview
  - 20.2.17.2 Products/Services offered
  - 20.2.17.3 Recent developments
    - 20.2.17.3.1 Product launches
- 20.2.18 MERCK KGAA
  - 20.2.18.1 Business overview
  - 20.2.18.2 Products/Services offered
  - 20.2.18.3 Recent developments
    - 20.2.18.3.1 Deals
    - 20.2.18.3.2 Expansions
- 20.2.19 BD
  - 20.2.19.1 Business overview
  - 20.2.19.2 Products/Services offered
  - 20.2.19.3 Recent developments
    - 20.2.19.3.1 Product launches and approvals
    - 20.2.19.3.2 Deals
- 20.2.20 ABBOTT
  - 20.2.20.1 Business overview
  - 20.2.20.2 Products/Services offered
- 20.2.21 10X GENOMICS
  - 20.2.21.1 Business overview
  - 20.2.21.2 Products/Services offered
  - 20.2.21.3 Recent developments
    - 20.2.21.3.1 Product launches
- 20.2.22 NEW ENGLAND BIOLABS
  - 20.2.22.1 Business overview
  - 20.2.22.2 Products/Services offered
  - 20.2.22.3 Recent developments
    - 20.2.22.3.1 Product launches
    - 20.2.22.3.2 Deals
- 20.2.23 PROMEGA CORPORATION
  - 20.2.23.1 Business overview
  - 20.2.23.2 Products/Services offered
  - 20.2.23.3 Recent developments
    - 20.2.23.3.1 Product launches
    - 20.2.23.3.2 Other developments
20.3 OTHER PLAYERS
- 20.3.1 CREATIVE BIOGENE
- 20.3.2 NOVOGENE CO., LTD.
- 20.3.3 HELIX, INC.
- 20.3.4 PHALANX BIOTECH GROUP
- 20.3.5 POLARIS GENOMICS

21 APPENDIX

21.1 DISCUSSION GUIDE
21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
21.3 CUSTOMIZATION OPTIONS
21.4 RELATED REPORTS
21.5 AUTHOR DETAILS

Product Code: BT 2209

List of Tables

TABLE 1 GENOMICS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3 GENOMICS MARKET: RISK ANALYSIS
TABLE 4 GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 5 GENOMICS MARKET: IMPACT OF PORTER'S FIVE FORCES
TABLE 6 GENOMICS MARKET: ROLE IN ECOSYSTEM
TABLE 7 GENOMICS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS
TABLE 8 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024 (USD)
TABLE 10 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)
TABLE 11 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024 (USD)
TABLE 12 IMPORT VALUE FOR HS CODE 3822, 2020-2024 (USD THOUSAND)
TABLE 13 IMPORT VOLUME FOR HS CODE 3822, 2020-2024 (TONS)
TABLE 14 IMPORT VALUE FOR HS CODE 902789, 2022-2024 (USD THOUSAND)
TABLE 15 IMPORT VOLUME FOR HS CODE 902789, 2022-2024 (UNITS)
TABLE 16 EXPORT VALUE FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 17 EXPORT VOLUME FOR HS CODE 3822, BY COUNTRY, 2019-2023 (TONS)
TABLE 18 EXPORT VALUE FOR HS CODE 902789, 2022-2024 (USD THOUSAND)
TABLE 19 EXPORT VOLUME FOR HS CODE 902789, 2022-2024 (UNITS)
TABLE 20 GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2026
TABLE 21 SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
TABLE 22 LONG-READ WHOLE GENOME SEQUENCING WAS USED IN CHILDREN'S MERCY KANSAS CITY
TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 24 GENOMICS MARKET: INDICATIVE LIST OF PATENTS, 2025
TABLE 25 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET
TABLE 26 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN GENOMICS
TABLE 27 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 29 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 30 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 31 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
TABLE 32 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
TABLE 34 KEY BUYING CRITERIA, BY END USER
TABLE 35 GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 36 GENOMICS PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 37 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 38 EUROPE: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 39 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 40 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 41 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 42 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 43 GENOMICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 44 NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 45 EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 47 LATIN AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 48 MIDDLE EAST: GENOMICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 49 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 50 GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 51 GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 52 NORTH AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 53 EUROPE: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 55 LATIN AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 56 MIDDLE EAST: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 57 GCC COUNTRIES: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 58 GENOMICS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 59 NORTH AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 60 EUROPE: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 62 LATIN AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 63 MIDDLE EAST: GENOMICS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 64 GCC COUNTRIES: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 65 GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 66 NORTH AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 67 EUROPE: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 68 ASIA PACIFIC: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 69 LATIN AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 70 MIDDLE EAST: GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 71 GCC COUNTRIES: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 72 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 73 SEQUENCING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 74 NORTH AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 75 EUROPE: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 76 ASIA PACIFIC: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 77 LATIN AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 78 MIDDLE EAST: SEQUENCING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 79 GCC COUNTRIES: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 80 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023-2030 (UNITS)
TABLE 81 PCR PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 82 NORTH AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 83 EUROPE: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 84 ASIA PACIFIC: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 85 LATIN AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 86 MIDDLE EAST: PCR PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 87 GCC COUNTRIES: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 88 GENE EDITING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 89 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 90 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 91 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 92 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 93 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 94 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 95 FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 96 NORTH AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 97 EUROPE: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 99 LATIN AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 100 MIDDLE EAST: FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 101 GCC COUNTRIES: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 102 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2023-2030 (UNITS)
TABLE 103 MICROARRAY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 104 NORTH AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 105 EUROPE: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 106 ASIA PACIFIC: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 107 LATIN AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 108 MIDDLE EAST: MICROARRAY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 109 GCC COUNTRIES: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 110 IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 111 NORTH AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 112 EUROPE: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 113 ASIA PACIFIC: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 114 LATIN AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 115 MIDDLE EAST: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 116 GCC COUNTRIES: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 117 GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 118 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 119 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 120 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 121 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 122 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 123 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 124 GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 125 GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 126 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 127 EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 128 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 129 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 130 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 131 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 132 GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 133 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 134 EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 135 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 136 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 137 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 138 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 139 GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 140 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 141 EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 142 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 143 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 144 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 145 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 146 GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023-2030 (USD MILLION)
TABLE 147 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 148 EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 149 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 150 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 151 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023-2030 (USD MILLION)
TABLE 152 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 153 GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 154 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 155 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 156 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 157 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 158 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 159 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 160 GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 161 GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 162 NORTH AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 163 EUROPE: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 164 ASIA PACIFIC: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 165 LATIN AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 166 MIDDLE EAST: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 167 GCC COUNTRIES: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 168 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 169 NORTH AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 170 EUROPE: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 171 ASIA PACIFIC: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 172 LATIN AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 173 MIDDLE EAST: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 174 GCC COUNTRIES: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 175 BIOINFORMATICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 176 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 177 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 178 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 179 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 180 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 181 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 182 GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 183 GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 184 NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 185 EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 186 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 187 LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 188 MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 189 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 190 GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 191 NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 192 EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 193 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 194 LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 195 MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 196 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 197 GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 198 NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 199 EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 200 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 201 LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 202 MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 203 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 204 GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 205 NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 206 EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 207 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 208 LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 209 MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 210 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 211 GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 212 GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 213 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 214 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 215 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 216 LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 217 MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 218 GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 219 GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 220 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 221 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 222 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 223 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 224 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 225 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 226 GENOMICS MARKET FOR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 227 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2025)
TABLE 228 GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 229 NORTH AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 230 EUROPE: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 231 ASIA PACIFIC: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 232 LATIN AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 233 MIDDLE EAST: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 234 GCC COUNTRIES: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 235 GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 236 NORTH AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 237 EUROPE: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 238 ASIA PACIFIC: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 239 LATIN AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 240 MIDDLE EAST: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 241 GCC COUNTRIES: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 242 GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023-2030 (USD MILLION)
TABLE 243 NORTH AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 244 EUROPE: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 245 ASIA PACIFIC: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 246 LATIN AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 247 MIDDLE EAST: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023-2030 (USD MILLION)
TABLE 248 GCC COUNTRIES: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 249 GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 250 NORTH AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 251 EUROPE: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 252 ASIA PACIFIC: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 253 LATIN AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 254 MIDDLE EAST: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 255 GCC COUNTRIES: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 256 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
TABLE 257 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 258 EUROPE: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 259 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 260 LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 261 MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
TABLE 262 GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 263 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 264 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 265 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 266 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 267 LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 268 MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 269 GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 270 GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 271 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 272 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 273 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 274 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 275 LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 276 MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 277 GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 278 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023-2030 (USD MILLION)
TABLE 279 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 280 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 281 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 282 LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 283 MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023-2030 (USD MILLION)
TABLE 284 GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 285 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
TABLE 286 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 287 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 288 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 289 LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 290 MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
TABLE 291 GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 292 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 293 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 294 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 295 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 296 LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 297 MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 298 GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 299 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023-2030 (USD MILLION)
TABLE 300 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 301 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 302 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 303 LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 304 MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023-2030 (USD MILLION)
TABLE 305 GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 306 GENOMICS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 307 NORTH AMERICA: KEY MACROINDICATORS
TABLE 308 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 309 NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 310 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 311 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 312 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 313 NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 314 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 315 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 316 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 317 NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 318 US: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 319 US: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 320 US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 321 US: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 322 US: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 323 US: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 324 US: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 325 US: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 326 US: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 327 CANADA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 328 CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 329 CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 330 CANADA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 331 CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 332 CANADA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 333 CANADA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 334 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 335 CANADA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 336 EUROPE: KEY MACROINDICATORS
TABLE 337 EUROPE: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 338 EUROPE: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 339 EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 340 EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 341 EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 342 EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 343 EUROPE: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 344 EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 345 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 346 EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 347 GERMANY: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 348 GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 349 GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 350 GERMANY: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 351 GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 352 GERMANY: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 353 GERMANY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 354 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 355 GERMANY: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 356 UK: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 357 UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 358 UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 359 UK: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 360 UK: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 361 UK: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 362 UK: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 363 UK: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 364 UK: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 365 FRANCE: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 366 FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 367 FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 368 FRANCE: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 369 FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 370 FRANCE: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 371 FRANCE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 372 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 373 FRANCE: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 374 ITALY: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 375 ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 376 ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 377 ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 378 ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 379 ITALY: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 380 ITALY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 381 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 382 ITALY: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 383 SPAIN: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 384 SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 385 SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 386 SPAIN: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 387 SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 388 SPAIN: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 389 SPAIN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 390 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 391 SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 392 REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 393 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 394 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 395 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 396 REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 397 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 398 REST OF EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 399 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 400 REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 401 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 402 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 403 ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 404 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 405 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 406 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 407 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 408 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 409 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 410 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 411 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 412 CHINA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 413 CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 414 CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 415 CHINA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 416 CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 417 CHINA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 418 CHINA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 419 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 420 CHINA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 421 JAPAN: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 422 JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 423 JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 424 JAPAN: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 425 JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 426 JAPAN: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 427 JAPAN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 428 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 429 JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 430 INDIA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 431 INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 432 INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 433 INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 434 INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 435 INDIA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 436 INDIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 437 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 438 INDIA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 439 AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 440 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 441 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 442 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 443 AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 444 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 445 AUSTRALIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 446 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 447 AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 448 SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 449 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 450 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 451 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 452 SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 453 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 454 SOUTH KOREA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 455 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 456 SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 457 REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 458 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 459 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 460 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 461 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 462 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 463 REST OF ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 464 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 465 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 466 LATIN AMERICA: KEY MACROINDICATORS
TABLE 467 LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 468 LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 469 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 470 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 471 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 472 LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 473 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 474 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 475 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 476 LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 477 BRAZIL: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 478 BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 479 BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 480 BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 481 BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 482 BRAZIL: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 483 BRAZIL: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 484 BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 485 BRAZIL: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 486 MEXICO: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 487 MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 488 MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 489 MEXICO: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 490 MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 491 MEXICO: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 492 MEXICO: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 493 MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 494 MEXICO: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 495 REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 496 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 497 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 498 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 499 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 500 REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 501 REST OF LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 502 REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 503 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 504 MIDDLE EAST: KEY MACROINDICATORS
TABLE 505 MIDDLE EAST: GENOMICS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 506 MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 507 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 508 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 509 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 510 MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 511 MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 512 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 513 MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 514 MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 515 GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 516 GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 517 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 518 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 519 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 520 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 521 GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 522 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 523 GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 524 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 525 SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 526 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 527 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 528 SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 529 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 530 SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 531 SAUDI ARABIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 532 SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 533 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 534 UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 535 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 536 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 537 UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 538 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 539 UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 540 UNITED ARAB EMIRATES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 541 UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 542 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 543 REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 544 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 545 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 546 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 547 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 548 REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 549 REST OF GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 550 REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 551 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 552 REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 553 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 554 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 555 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 556 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 557 REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 558 REST OF MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 559 REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 560 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 561 AFRICA: KEY MACROINDICATORS
TABLE 562 AFRICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
TABLE 563 AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 564 AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 565 AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 566 AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 567 AFRICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 568 AFRICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 569 AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
TABLE 570 AFRICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 571 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENOMICS MARKET, JANUARY 2022-OCTOBER 2025
TABLE 572 GENOMICS PRODUCTS MARKET: DEGREE OF COMPETITION
TABLE 573 MARKET RANK OF KEY PLAYERS IN GENOMICS SERVICES MARKET (2024)
TABLE 574 GENOMICS MARKET: REGION FOOTPRINT
TABLE 575 GENOMICS MARKET: PRODUCT FOOTPRINT
TABLE 576 GENOMICS MARKET: APPLICATION FOOTPRINT
TABLE 577 GENOMICS MARKET: TECHNOLOGY FOOTPRINT
TABLE 578 GENOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 579 GENOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
TABLE 580 GENOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 581 GENOMICS MARKET: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 582 GENOMICS MARKET: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 583 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 584 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 585 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
TABLE 586 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 587 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 588 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 589 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 590 ILLUMINA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
TABLE 591 ILLUMINA, INC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 592 ILLUMINA, INC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 593 ILLUMINA, INC.: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
TABLE 594 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 595 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 596 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 597 DANAHER CORPORATION: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 598 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 599 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 600 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 601 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 602 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 603 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
TABLE 604 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 605 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 606 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 607 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 608 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 609 QIAGEN: COMPANY OVERVIEW
TABLE 610 QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 611 QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
TABLE 612 QIAGEN: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 613 QIAGEN: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 614 REVVITY: COMPANY OVERVIEW
TABLE 615 REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 616 REVVITY: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 617 REVVITY: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 618 REVVITY: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 619 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
TABLE 620 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
TABLE 621 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 622 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 623 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 624 IQVIA INC.: COMPANY OVERVIEW
TABLE 625 IQVIA INC.: SERVICES OFFERED
TABLE 626 IQVIA INC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 627 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
TABLE 628 CHARLES RIVER LABORATORIES: SERVICES OFFERED
TABLE 629 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 630 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 631 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
TABLE 632 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 633 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 634 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 635 EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 636 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 637 PACBIO: COMPANY OVERVIEW
TABLE 638 PACBIO: PRODUCTS/SERVICES OFFERED
TABLE 639 PACBIO: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 640 PACBIO: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 641 PACBIO: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 642 PACBIO: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
TABLE 643 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW
TABLE 644 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED
TABLE 645 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 646 OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 647 OXFORD NANOPORE TECHNOLOGIES PLC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 648 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 649 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
TABLE 650 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 651 TAKARA BIO INC.: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 652 BGI GROUP: COMPANY OVERVIEW
TABLE 653 BGI GROUP: PRODUCTS/SERVICES OFFERED
TABLE 654 BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
TABLE 655 BGI GROUP: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 656 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
TABLE 657 EPPENDORF SE: COMPANY OVERVIEW
TABLE 658 EPPENDORF SE: PRODUCTS/SERVICES OFFERED
TABLE 659 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 660 MERCK KGAA: COMPANY OVERVIEW
TABLE 661 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 662 MERCK KGAA: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 663 MERCK KGAA: EXPANSIONS, JANUARY 2022-OCTOBER 2025
TABLE 664 BD: COMPANY OVERVIEW
TABLE 665 BD: PRODUCTS/SERVICES OFFERED
TABLE 666 BD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
TABLE 667 BD: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 668 ABBOTT: COMPANY OVERVIEW
TABLE 669 ABBOTT: PRODUCTS/SERVICES OFFERED
TABLE 670 10X GENOMICS: COMPANY OVERVIEW
TABLE 671 10X GENOMICS: PRODUCTS/SERVICES OFFERED
TABLE 672 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 673 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
TABLE 674 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
TABLE 675 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2021- SEPTEMBER 2024
TABLE 676 NEW ENGLAND BIOLABS: DEALS, JANUARY 2022-OCTOBER 2025
TABLE 677 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 678 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 679 PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
TABLE 680 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
TABLE 681 CREATIVE BIOGENE: COMPANY OVERVIEW
TABLE 682 NOVOGENE CO., LTD.: COMPANY OVERVIEW
TABLE 683 HELIX, INC.: COMPANY OVERVIEW
TABLE 684 PHALANX BIOTECH GROUP: COMPANY OVERVIEW
TABLE 685 POLARIS GENOMICS: COMPANY OVERVIEW

List of Figures

FIGURE 1 GENOMICS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 GENOMICS MARKET: YEARS CONSIDERED
FIGURE 3 GENOMICS MARKET: RESEARCH DESIGN
FIGURE 4 GENOMICS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
FIGURE 5 GLOBAL GENOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 6 GLOBAL GENOMICS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
FIGURE 7 GENOMICS MARKET SIZE VALIDATION FROM INDUSTRY EXPERTS
FIGURE 8 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 9 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY (COMPANY REVENUE ANALYSIS)
FIGURE 10 GLOBAL GENOMICS MARKET: CAGR PROJECTIONS (2025-2030)
FIGURE 11 DATA TRIANGULATION
FIGURE 12 GENOMICS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
FIGURE 13 GENOMICS PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 14 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 15 GENOMICS PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 16 GENOMICS SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17 GENOMICS SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18 GENOMICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19 GENOMICS MARKET, BY STUDY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20 REGIONAL SNAPSHOT OF GENOMICS MARKET
FIGURE 21 INCREASING GOVERNMENT FUNDING FOR GENOMICS PROJECTS TO PROPEL MARKET GROWTH
FIGURE 22 US AND DRUG DISCOVERY & DEVELOPMENT COMMANDED LARGEST MARKET SHARES IN 2024
FIGURE 23 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
FIGURE 24 GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25 BURDEN OF HIV INFECTIONS, BY REGION, 2024
FIGURE 26 GENOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 27 GROWTH OF GLOBAL GDP FROM 2020 TO 2024, WITH FORECASTS UNTIL 2030
FIGURE 28 GENOMICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 29 GENOMICS MARKET ECOSYSTEM
FIGURE 30 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024 (USD)
FIGURE 31 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024 (USD)
FIGURE 32 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024 (USD)
FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN GENOMICS MARKET
FIGURE 34 PE/VC INVESTMENTS IN LIFE SCIENCES SPLIT BETWEEN PHARMACEUTICALS AND HEALTHCARE
FIGURE 35 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014-2024
FIGURE 36 IMPACT OF AI/GEN AI ON GENOMICS MARKET
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 38 KEY BUYING CRITERIA, BY END USER
FIGURE 39 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
FIGURE 40 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET, 2020-2024 (USD BILLION)
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOMICS PRODUCTS MARKET (2024)
FIGURE 43 GENOMICS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 44 GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 45 GENOMICS MARKET: COMPANY FOOTPRINT
FIGURE 46 GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 47 EV/EBITDA OF KEY VENDORS
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 50 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 52 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 54 QIAGEN: COMPANY SNAPSHOT (2024)
FIGURE 55 REVVITY: COMPANY SNAPSHOT (2024)
FIGURE 56 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2024)
FIGURE 57 IQVIA INC.: COMPANY SNAPSHOT (2024)
FIGURE 58 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 60 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
FIGURE 61 PACBIO: COMPANY SNAPSHOT (2024)
FIGURE 62 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2024)
FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
FIGURE 64 EPPENDORF SE: COMPANY SNAPSHOT (2024)
FIGURE 65 MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 66 BD: COMPANY SNAPSHOT (2024)
FIGURE 67 ABBOTT: COMPANY SNAPSHOT (2024)
FIGURE 68 10X GENOMICS: COMPANY SNAPSHOT (2024)

Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights into the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 INDUSTRY TRENDS

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

8 SUSTAINABILITY AND REGULATORY LANDSCAPE

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

10 GENOMICS MARKET, BY OFFERING

11 GENOMICS PRODUCTS MARKET, BY TYPE

12 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY

13 GENOMICS PRODUCTS MARKET, BY END USER

14 GENOMICS SERVICES MARKET, BY TYPE

15 GENOMICS SERVICES MARKET, BY END USER

16 GENOMICS MARKET, BY APPLICATION

17 GENOMICS MARKET, BY STUDY TYPE

18 GENOMICS MARKET, BY REGION

19 COMPETITIVE LANDSCAPE

20 COMPANY PROFILES

21 APPENDIX

List of Tables

List of Figures